{"id":"https://openalex.org/W4362432390","doi":"https://doi.org/10.1158/1078-0432.22481073","title":"Supplemental Figure 3 from Long-term Follow-up and Correlative Analysis of Two Phase II Trials of Rituximab and Lenalidomide Followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent Lymphoma","display_name":"Supplemental Figure 3 from Long-term Follow-up and Correlative Analysis of Two Phase II Trials of Rituximab and Lenalidomide Followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent Lymphoma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4362432390","doi":"https://doi.org/10.1158/1078-0432.22481073"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22481073","doi":"https://doi.org/10.1158/1078-0432.22481073","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22481073","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Figure_3_from_Long-term_Follow-up_and_Correlative_Analysis_of_Two_Phase_II_Trials_of_Rituximab_and_Lenalidomide_Followed_by_Continuous_Lenalidomide_in_Untreated_and_Relapsed_Refractory_Indolent_Lymphoma/22481073/1/files/39932583.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Figure_3_from_Long-term_Follow-up_and_Correlative_Analysis_of_Two_Phase_II_Trials_of_Rituximab_and_Lenalidomide_Followed_by_Continuous_Lenalidomide_in_Untreated_and_Relapsed_Refractory_Indolent_Lymphoma/22481073/1/files/39932583.pdf","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045079164","display_name":"Joseph M. Tuscano","orcid":"https://orcid.org/0000-0002-0522-1406","observed_orcids":["https://orcid.org/0000-0002-0522-1406"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph M. Tuscano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054146743","display_name":"Christina Poh","orcid":"https://orcid.org/0000-0003-3120-712X","observed_orcids":["https://orcid.org/0000-0003-3120-712X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christina Poh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066543172","display_name":"Paul R. Kaesberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Kaesberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084956764","display_name":"Guillaume Luxardi","orcid":"https://orcid.org/0000-0003-3338-0583","observed_orcids":["https://orcid.org/0000-0003-3338-0583"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guilluame Luxardi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3338-0583","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032164345","display_name":"Alexander A. Merleev","orcid":"https://orcid.org/0000-0002-5735-7233","observed_orcids":["https://orcid.org/0000-0002-5735-7233","https://orcid.org/0000-0002-5031-4775"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander Merleev","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5735-7233","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076958813","display_name":"Alina I. Marusina","orcid":"https://orcid.org/0000-0002-2352-315X","observed_orcids":["https://orcid.org/0000-0002-2352-315X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alina Marusina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060558335","display_name":"Ann M. Brunson","orcid":"https://orcid.org/0000-0001-5308-9457","observed_orcids":["https://orcid.org/0000-0001-5308-9457"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ann Brunson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Aaron Rosenberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aaron Rosenberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068133376","display_name":"Brian Andrew Jonas","orcid":"https://orcid.org/0000-0002-4921-5809","observed_orcids":["https://orcid.org/0000-0002-4921-5809"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian Jonas","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4921-5809","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5030729248","display_name":"Emanual Michael Maverakis","orcid":"https://orcid.org/0000-0002-6294-6294","observed_orcids":["https://orcid.org/0000-0002-6294-6294"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emanual Maverakis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6294-6294","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9700000286102295},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":1.0},{"id":"https://openalex.org/keywords/indolent-lymphoma","display_name":"indolent lymphoma","score":0.9660000205039978},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.6809999942779541},{"id":"https://openalex.org/keywords/nkt-cells","display_name":"NKT cells","score":0.9900000095367432},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9900000095367432},{"id":"https://openalex.org/keywords/flow-cytometry","display_name":"flow cytometry","score":0.6990000009536743},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.9200000166893005},{"id":"https://openalex.org/keywords/previously-untreated-lymphoma","display_name":"previously untreated lymphoma","score":0.6050000190734863},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.699999988079071}],"concepts":[{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.9345471858978271},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6011317372322083},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5694745779037476},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4925912022590637},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48012638092041016},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4530408978462219},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.3820565640926361},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.17644891142845154},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10827654600143433},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22481073","doi":"https://doi.org/10.1158/1078-0432.22481073","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22481073","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Figure_3_from_Long-term_Follow-up_and_Correlative_Analysis_of_Two_Phase_II_Trials_of_Rituximab_and_Lenalidomide_Followed_by_Continuous_Lenalidomide_in_Untreated_and_Relapsed_Refractory_Indolent_Lymphoma/22481073/1/files/39932583.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22481073","doi":"https://doi.org/10.1158/1078-0432.22481073","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22481073","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Figure_3_from_Long-term_Follow-up_and_Correlative_Analysis_of_Two_Phase_II_Trials_of_Rituximab_and_Lenalidomide_Followed_by_Continuous_Lenalidomide_in_Untreated_and_Relapsed_Refractory_Indolent_Lymphoma/22481073/1/files/39932583.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362432390.pdf","grobid_xml":"https://content.openalex.org/works/W4362432390.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2586476291","https://openalex.org/W2950334334","https://openalex.org/W2590670816","https://openalex.org/W3164387393","https://openalex.org/W4361947385","https://openalex.org/W70887471","https://openalex.org/W2366259842","https://openalex.org/W2566659883","https://openalex.org/W4248032205","https://openalex.org/W2615631762"],"abstract_inverted_index":{"Flow":[0],"cytometric":[1],"analysis":[2],"of":[3],"NK,":[4],"NK":[5],"T":[6],"cell":[7],"and":[8],"Treg":[9],"subpopulations.":[10]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2023-04-05T00:00:00"}